{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:55:00Z","timestamp":1789682100176,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1023\/b:brea.0000025402.70958.3e","type":"journal-article","created":{"date-parts":[[2004,4,27]],"date-time":"2004-04-27T00:19:29Z","timestamp":1083025169000},"page":"133-142","source":"Crossref","is-referenced-by-count":13,"title":["Hormonal Factors and Breast Tumor Proliferation: Do Factors that Affect Cancer Risk also Affect Tumor Growth?"],"prefix":"10.1007","volume":"85","author":[{"given":"Nina","family":"Oestreicher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy L.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"5265003_CR1","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1016\/S0021-9258(17)42922-X","volume":"259","author":"J Schneider","year":"1984","unstructured":"Schneider J, Huh MM, Bradlow HL, Fishman J: Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 259: 4840\u20134845, 1984","journal-title":"J Biol Chem"},{"key":"5265003_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0303-7207(93)90076-V","volume":"92","author":"M Noguchi","year":"1993","unstructured":"Noguchi M, Thomas M, Koyasaki N et al.: Influence of hormones on tumor growth, cell kinetics, estrogen receptor and insulin-like growth factor-I-related protein of human breast cancer (MCF-7) cells transplanted in nude mice. Mol Cell Endocrinol 92: 69\u201376, 1993","journal-title":"Mol Cell Endocrinol"},{"key":"5265003_CR3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF01806774","volume":"6","author":"V Hug","year":"1985","unstructured":"Hug V, Drewinko B, Hortobagyi GN, Blumenschein G: Regulation of breast tumor growth by high dose estrogen is independent of the presence of estrogen receptors. Breast Cancer Res Treat 6: 237\u2013240, 1985","journal-title":"Breast Cancer Res Treat"},{"key":"5265003_CR4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Writing Group for the Women","year":"2002","unstructured":"Writing Group for the Women\u2019s Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA 288: 321\u2013333, 2002","journal-title":"JAMA"},{"key":"5265003_CR5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jama.287.6.734","volume":"287","author":"CL Chen","year":"2002","unstructured":"Chen CL, Weiss NS, Newcomb P, Barlow W, White E: Hormone replacement therapy in relation to breast cancer. JAMA 287: 734\u2013741, 2002","journal-title":"JAMA"},{"key":"5265003_CR6","first-page":"593","volume":"11","author":"PA Newcomb","year":"2002","unstructured":"Newcomb PA, Titus-Ernstoff L, Egan KM et al.: Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 11: 593\u2013600, 2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5265003_CR7","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/jnci\/90.11.814","volume":"90","author":"GA Colditz","year":"1998","unstructured":"Colditz GA: Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 90: 814\u2013823, 1998","journal-title":"J Natl Cancer Inst"},{"key":"5265003_CR8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3181\/00379727-216-44153B","volume":"216","author":"MP Cleary","year":"1997","unstructured":"Cleary MP, Maihle NJ: The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med 216: 28\u201343, 1997","journal-title":"Proc Soc Exp Biol Med"},{"key":"5265003_CR9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1997","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047\u20131059, 1997","journal-title":"Lancet"},{"key":"5265003_CR10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.pu.17.050196.000403","volume":"17","author":"JL Kelsey","year":"1996","unstructured":"Kelsey JL, Bernstein L: Epidemiology and prevention of breast cancer. Annu Rev Public Health 17: 47\u201367, 1996","journal-title":"Annu Rev Public Health"},{"key":"5265003_CR11","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/1097-0142(19870515)59:10<1744::AID-CNCR2820591012>3.0.CO;2-D","volume":"59","author":"JF McGurrin","year":"1987","unstructured":"McGurrin JF, Doria MI Jr., Dawson PJ, Karrison T, Stein HO, Franklin WA: Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast. Cancer 59: 1744\u20131750, 1987","journal-title":"Cancer"},{"key":"5265003_CR12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/1097-0142(19880201)61:3<420::AID-CNCR2820610303>3.0.CO;2-0","volume":"61","author":"LG Dressler","year":"1988","unstructured":"Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL: DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61: 420\u2013427, 1988","journal-title":"Cancer"},{"key":"5265003_CR13","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/1097-0142(19810815)48:4<974::AID-CNCR2820480420>3.0.CO;2-#","volume":"48","author":"C Gentili","year":"1981","unstructured":"Gentili C, Sanfilippo O, Silvestrini R: Cell proliferation and its relationship to clinical features and relapse in breast cancers. Cancer 48: 974\u2013979, 1981","journal-title":"Cancer"},{"key":"5265003_CR14","first-page":"83","volume":"31","author":"J Mirecka","year":"1993","unstructured":"Mirecka J, Korabiowska M, Schauer A: Correlation between the occurrence of Ki-67 antigen and clinical parameters in human breast carcinoma. Folia Histochem Cytobiol 31: 83\u201386, 1993","journal-title":"Folia Histochem Cytobiol"},{"key":"5265003_CR15","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/1097-0142(19830515)51:10<1879::AID-CNCR2820511021>3.0.CO;2-9","volume":"51","author":"JS Meyer","year":"1983","unstructured":"Meyer JS, Friedman E, McCrate MM, Bauer WC: Prediction of early course of breast carcinoma by thymidine labeling. Cancer 51: 1879\u20131886, 1983","journal-title":"Cancer"},{"key":"5265003_CR16","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/(SICI)1097-0142(19960915)78:6<1220::AID-CNCR8>3.0.CO;2-D","volume":"78","author":"CT Brekelmans","year":"1996","unstructured":"Brekelmans CT, van Gorp JM, Peeters PH, Collette HJ: Histopathology and growth rate of interval breast carcinoma. Characterization of different subgroups. Cancer 78: 1220\u20131228, 1996","journal-title":"Cancer"},{"key":"5265003_CR17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/jnci\/92.7.550","volume":"92","author":"SG Diab","year":"2000","unstructured":"Diab SG, Elledge RM, Clark GM: Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92: 550\u2013556, 2000","journal-title":"J Natl Cancer Inst"},{"key":"5265003_CR18","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/1097-0142(19891101)64:9<1894::AID-CNCR2820640923>3.0.CO;2-K","volume":"64","author":"HB Muss","year":"1989","unstructured":"Muss HB, Kute TE, Case LD et al.: The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer. Cancer 64: 1894\u20131900, 1989","journal-title":"Cancer"},{"key":"5265003_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01806145","volume":"38","author":"H Romero","year":"1996","unstructured":"Romero H, Schneider J, Burgos J, Bilbao J, Rodriguez-Escudero FJ: S-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers. Breast Cancer Res Treat 38: 265\u2013275, 1996","journal-title":"Breast Cancer Res Treat"},{"key":"5265003_CR20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bmj.2.5299.213","volume":"2","author":"HJG Bloom","year":"1962","unstructured":"Bloom HJG, Richardson WW, Harries EJ: Natural history of untreated breast cancer (1805-1933): comparison of untreated and treated cases according to histologic grade of malignancy. Br Med J 2: 213\u2013221, 1962","journal-title":"Br Med J"},{"key":"5265003_CR21","first-page":"571","volume":"18","author":"C Genestie","year":"1998","unstructured":"Genestie C, Zafrani B, Asselain B et al.: Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems. Anticancer Res 18: 571\u2013576, 1998","journal-title":"Anticancer Res"},{"key":"5265003_CR22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1097-0142(19910915)68:6<1309::AID-CNCR2820680621>3.0.CO;2-I","volume":"68","author":"F Clayton","year":"1991","unstructured":"Clayton F: Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor. Cancer 68: 1309\u20131317, 1991","journal-title":"Cancer"},{"key":"5265003_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1006344010050","volume":"59","author":"WH Goodson III","year":"2000","unstructured":"Goodson WH III, Moore DH II, Ljung BM et al.: The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67. Breast Cancer Res Treat 59: 113\u2013123, 2000","journal-title":"Breast Cancer Res Treat"},{"key":"5265003_CR24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/(SICI)1097-0215(19970822)74:4<433::AID-IJC12>3.0.CO;2-A","volume":"74","author":"A Molino","year":"1997","unstructured":"Molino A, Micciolo R, Turazza M et al.: Ki-67 immunostaining in 322 primary breast cancers: associations with clinical and pathological variables and prognosis. Int J Cancer 74: 433\u2013437, 1997","journal-title":"Int J Cancer"},{"key":"5265003_CR25","first-page":"585","volume":"2","author":"RW Brown","year":"1996","unstructured":"Brown RW, Allred CD, Clark GM, Osborne CK, Hilsenbeck SG: Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer. Clin Cancer Res 2: 585\u2013592, 1996","journal-title":"Clin Cancer Res"},{"key":"5265003_CR26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00665767","volume":"32","author":"M Rudas","year":"1994","unstructured":"Rudas M, Gnant MF, Mittlbock M et al.: Thymidine labeling index and Ki-67 growth fraction in breast cancer: comparison and correlation with prognosis. Breast Cancer Res Treat 32: 165\u2013175, 1994","journal-title":"Breast Cancer Res Treat"},{"key":"5265003_CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1097-0142(19910115)67:2<421::AID-CNCR2820670217>3.0.CO;2-Q","volume":"67","author":"HO Wintzer","year":"1991","unstructured":"Wintzer HO, Zipfel I, Schulte-Monting J, Hellerich U, von Kleist S: Ki-67 immunostaining in human breast tumors and its relationship to prognosis. Cancer 67: 421\u2013428, 1991","journal-title":"Cancer"},{"key":"5265003_CR28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0091-7435(87)90003-X","volume":"16","author":"AP Carter","year":"1987","unstructured":"Carter AP, Thompson RS, Bourdeau RV, Andenes J, Mustin H, Straley H: A clinically effective breast cancer screening program can be cost-effective, too. Prev Med 16: 19\u201334, 1987","journal-title":"Prev Med"},{"key":"5265003_CR29","first-page":"625","volume":"6","author":"SH Taplin","year":"1997","unstructured":"Taplin SH, Mandelson MT, Anderman C et al.:Mammography diffusion and trends in late-stage breast cancer: evaluating outcomes in a population. Cancer Epidemiol Biomarkers Prev 6: 625\u2013631, 1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5265003_CR30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403\u2013410, 1991","journal-title":"Histopathology"},{"key":"5265003_CR31","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0046-8177(99)90062-X","volume":"30","author":"HA Lehr","year":"1999","unstructured":"Lehr HA, Hansen DA, Kussick S et al.: Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count. Hum Pathol 30: 1314\u20131320, 1999","journal-title":"Hum Pathol"},{"key":"5265003_CR32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/00000478-199310000-00003","volume":"17","author":"N Weidner","year":"1993","unstructured":"Weidner N, Moore DH II, Ljung BM et al.: Correlation of bromodeoxyuridine (BRDU) labeling of breast carcinoma cells 142 N Oestreicher et al. with mitotic figure content and tumor grade. Am J Surg Pathol 17: 987\u2013994, 1993","journal-title":"Am J Surg Pathol"},{"key":"5265003_CR33","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/1097-0142(19891101)64:9<1901::AID-CNCR2820640924>3.0.CO;2-W","volume":"64","author":"J Andersen","year":"1989","unstructured":"Andersen J, Poulsen HS: Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer. Cancer 64: 1901\u20131908, 1989","journal-title":"Cancer"},{"key":"5265003_CR34","first-page":"709","volume":"11","author":"V Ravn","year":"1998","unstructured":"Ravn V, Havsteen H, Thorpe SM: Immunohistochemical evaluation of estrogen and progesterone receptors in paraffinembedded, formalin-fixed endometrial tissues: comparison with enzyme immunoassay and immunohistochemical analysis of frozen tissue. Mod Pathol 11: 709\u2013715, 1998","journal-title":"Mod Pathol"},{"key":"5265003_CR35","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1365-2559.2000.01006.x","volume":"37","author":"B Zafrani","year":"2000","unstructured":"Zafrani B, Aubriot MH, Mouret E et al.: High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases. Histopathology 37: 536\u2013545, 2000","journal-title":"Histopathology"},{"key":"5265003_CR36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/path.1711680404","volume":"168","author":"G Cattoretti","year":"1992","unstructured":"Cattoretti G, Becker MH, Key G et al.: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357\u2013363, 1992","journal-title":"J Pathol"},{"key":"5265003_CR37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nm0297-222","volume":"3","author":"PL Porter","year":"1997","unstructured":"Porter PL, Malone KE, Heagerty PJ et al.: Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3: 222\u2013225, 1997","journal-title":"Nat Med"},{"key":"5265003_CR38","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/jnci\/88.11.756","volume":"88","author":"N Potischman","year":"1996","unstructured":"Potischman N, Swanson CA, Siiteri P, Hoover RN: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 88: 756\u2013758, 1996","journal-title":"J Natl Cancer Inst"},{"key":"5265003_CR39","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/bjc.1996.632","volume":"74","author":"RA Walker","year":"1996","unstructured":"Walker RA, Lees E, Webb MB, Dearing SJ: Breast carcinomas occurring in young women (<35 years) are different. Br J Cancer 74: 1796\u20131800, 1996","journal-title":"Br J Cancer"},{"key":"5265003_CR40","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/bjs.1800830805","volume":"83","author":"SE Reid","year":"1996","unstructured":"Reid SE, Murthy MS, Kaufman M, Scanlon EF: Endocrine and paracrine hormones in the promotion, progression and recurrence of breast cancer. Br J Surg 83: 1037\u20131046, 1996","journal-title":"Br J Surg"},{"key":"5265003_CR41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01806214","volume":"40","author":"H Olsson","year":"1996","unstructured":"Olsson H, Jernstrom H, Alm P et al.: Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors. Breast Cancer Res Treat 40: 187\u2013196, 1996","journal-title":"Breast Cancer Res Treat"},{"key":"5265003_CR42","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ijc.2910410505","volume":"41","author":"F de Waard","year":"1988","unstructured":"de Waard F, Trichopoulos D: A unifying concept of the aetiology of breast cancer. Int J Cancer 41: 666\u2013669, 1988","journal-title":"Int J Cancer"},{"key":"5265003_CR43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1097-0142(19950715)76:2<275::AID-CNCR2820760218>3.0.CO;2-6","volume":"76","author":"S Zhang","year":"1995","unstructured":"Zhang S, Folsom AR, Sellers TA, Kushi LH, Potter JD: Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women\u2019s Health Study. Cancer 76: 275\u2013283, 1995","journal-title":"Cancer"},{"key":"5265003_CR44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/ije\/26.3.484","volume":"26","author":"SC Newman","year":"1997","unstructured":"Newman SC, Lees AW, Jenkins HJ: The effect of body mass index and oestrogen receptor level on survival of breast cancer patients. Int J Epidemiol 26: 484\u2013490, 1997","journal-title":"Int J Epidemiol"},{"key":"5265003_CR45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/oxfordjournals.jncimonographs.a024245","volume":"27","author":"JD Yager","year":"2000","unstructured":"Yager JD: Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 27: 67\u201373, 2000","journal-title":"J Natl Cancer Inst Monogr"},{"key":"5265003_CR46","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jama.281.16.1528","volume":"281","author":"MA Cobleigh","year":"1999","unstructured":"Cobleigh MA, Norlock FE, Oleske DM, Starr A: Hormone replacement therapy and high S phase in breast cancer. JAMA 281: 1528\u20131530, 1999","journal-title":"JAMA"},{"key":"5265003_CR47","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1200\/JCO.1998.16.9.3115","volume":"16","author":"K Holli","year":"1998","unstructured":"Holli K, Isola J, Cuzick J: Low biologic aggressiveness in breast cancer in women using hormone replacement therapy. J Clin Oncol 16: 3115\u20133120, 1998","journal-title":"J Clin Oncol"},{"key":"5265003_CR48","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/oxfordjournals.aje.a115817","volume":"133","author":"DR Friedman","year":"1991","unstructured":"Friedman DR, Dubin N: Case-control evaluation of breast cancer screening efficacy. Am J Epidemiol 133: 974\u2013984, 1991","journal-title":"Am J Epidemiol"},{"key":"5265003_CR49","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1089\/152460999319138","volume":"8","author":"ES LeBlanc","year":"1999","unstructured":"LeBlanc ES, Viscoli CM, Henrich JB: Postmenopausal estrogen replacement therapy is associated with adverse breast cancer prognostic indices. J Womens Health Gend Based Med 8: 815\u2013823, 1999","journal-title":"J Womens Health Gend Based Med"},{"key":"5265003_CR50","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/archsurg.137.9.1015","volume":"137","author":"J Cheek","year":"2002","unstructured":"Cheek J, Lacy J, Toth-Fejel S, Morris K, Calhoun K, Pommier RF: The impact of hormone replacement therapy on the detection and stage of breast cancer. Arch Surg 137: 1015\u20131019, 2002","journal-title":"Arch Surg"},{"key":"5265003_CR51","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/jnci\/91.3.264","volume":"91","author":"C Schairer","year":"1999","unstructured":"Schairer C, Gail M, Byrne C et al.: Estrogen replacement therapy and breast cancer survival in a large screening study. J Natl Cancer Inst 91: 264\u2013270, 1999","journal-title":"J Natl Cancer Inst"},{"key":"5265003_CR52","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199706193362501","volume":"336","author":"F Grodstein","year":"1997","unstructured":"Grodstein F, Stampfer MJ, Colditz GA et al.: Postmenopausal hormone therapy and mortality. N Engl J Med 336: 1769\u20131775, 1997","journal-title":"N Engl J Med"},{"key":"5265003_CR53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0029-7844(94)00324-7","volume":"85","author":"P Bonnier","year":"1995","unstructured":"Bonnier P, Romain S, Giacalone PL, Laffargue F, Martin PM, Piana L: Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy. Obstet Gynecol 85: 11\u201317, 1995","journal-title":"Obstet Gynecol"},{"key":"5265003_CR54","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/sj.bjc.6690543","volume":"80","author":"H Jernstrom","year":"1999","unstructured":"Jernstrom H, Frenander J, Ferno M, Olsson H: Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients. Br J Cancer 80: 1453\u20131458, 1999","journal-title":"Br J Cancer"},{"key":"5265003_CR55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1067\/mob.2002.121077","volume":"186","author":"K Nanda","year":"2002","unstructured":"Nanda K, Bastian LA, Schulz K: Hormone replacement therapy and the risk of death from breast cancer: a systematic review. Am J Obstet Gynecol 186: 325\u2013334, 2002","journal-title":"Am J Obstet Gynecol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:BREA.0000025402.70958.3e.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:BREA.0000025402.70958.3e\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/B:BREA.0000025402.70958.3e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:BREA.0000025402.70958.3e.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T23:26:09Z","timestamp":1750893969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:BREA.0000025402.70958.3e"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["5265003"],"URL":"https:\/\/doi.org\/10.1023\/b:brea.0000025402.70958.3e","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}